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Background: Fatigue in multiple sclerosis (MS) patients appears to correlate with 
vigilance decrement as reflected in an increase in reaction time (RT) and errors with 
prolonged time-on-task.
Objectives: The aim of this study was to investigate whether anodal transcranial direct 
current stimulation (tDCS) over the right parietal or frontal cortex counteracts fatigue-as-
sociated vigilance decrement and subjective fatigue.
Methods: In study I, a randomized double-blind placebo-controlled study, anodal tDCS 
(1.5 mA) was delivered to the right parietal cortex or the right frontal cortex of 52 healthy 
participants during the first 20 min of a 40-min lasting visual vigilance task. Study II, also 
a randomized double-blind placebo-controlled study, investigated the effect of anodal 
tDCS (1.5 mA) over the right parietal cortex in 46 MS patients experiencing cognitive 
fatigue. tDCS was delivered for 20 min before patients performed a 20-min lasting visual 
vigilance task.
results: Study I showed that right parietal stimulation, but not right frontal stimulation, 
counteracts the increase in RT associated with vigilance decrement. Hence, only right 
parietal stimulation was applied to the MS patients in study II. Stimulation had a significant 
effect on vigilance decrement in mildly to moderately cognitively fatigued MS patients. 
Vigilance testing significantly increased the feeling of fatigue independent of stimulation.
conclusion: Anodal tDCS over the right parietal cortex can counteract the increase in 
RTs during vigilance performance, but not the increase in subjective fatigue. This finding 
is compatible with our model of fatigue in MS, suggesting a dissociation between the 
feeling and the behavioral characteristics of fatigue.
Keywords: multiple sclerosis, vigilance decrement, subjective fatigue, anodal tDcs, right parietal cortex, right 
frontal cortex
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inTrODUcTiOn
Several studies on the relation between fatigue and cognitive 
performance in multiple sclerosis (MS) patients found evidence 
for a relation between fatigue and vigilance (1–5). Vigilance tasks 
require an individual to sustain attention during a repetitive 
monotonous task over a prolonged period of time (6). Usually, 
detection performance in vigilance tasks declines during 
time-on-task, which is known as vigilance decrement (7). This 
vigilance decrement strongly correlates with self-reported fatigue 
and appears approximately after 20–30 min, reflecting in longer 
reaction times (RTs) and an increase in errors (8–13). Moreover, 
vigilance tasks are also highly sensitive to fatigue and sleep dep-
rivation (14, 15).
Previous studies demonstrated that MS patients with fatigue 
present a larger vigilance decrement than healthy controls (2, 16). 
Moreover, several studies found correlations between fatigue and 
vigilance decrement in MS patients (3, 5, 17). Therefore, vigilance 
tasks appear to be well suited to measure fatigue in MS.
Neuroanatomically, vigilance relies on a right-hemispheric 
frontal, parietal, thalamic, and brainstem network (18–20). 
Several functional imaging studies demonstrated an association 
between vigilant attention and brain activity in right-hemispheric 
cortical areas, such as the dorsomedial, mid- and ventrolateral 
prefrontal cortex, the anterior insula, the intraparietal sulcus, 
and the temporo–parietal junction, as well as in subcortical areas, 
such as the cerebellar vermis, the thalamus, the putamen, and the 
midbrain (21). Cognitive neuroscience research has consistently 
documented an association between decreased activity within 
this vigilance network and a decrease in vigilance performance 
with time-on-task (11, 22–24).
Considering MS-related fatigue, its pathophysiology has not 
been well elucidated. It seems that several factors contribute to 
fatigue in MS. Fatigue may be a direct consequence of the disease 
process (primary fatigue) or it may be due to MS-related comor-
bidities (secondary fatigue). Proposed mechanisms for primary 
fatigue include immune system dysfunction, neuroendocrine 
dysregulation, demyelination and axonal loss, gray matter 
atrophy as well as functional abnormalities within various brain 
networks (25, 26). Concerning structural and functional changes 
in the central nervous system, especially changes in right frontal 
and parietal brain areas, which constitute the vigilance network, 
have been associated with fatigue in MS patients (27–37).
Transcranial direct current stimulation (tDCS) is a non-
invasive technique for modulating neuronal activity (38). Anodal 
tDCS has been found to enhance neural activity, accompanied 
by an increase in cerebral blood flow in regions under the anode 
(39, 40). Consequently, anodal tDCS over brain regions that 
show decreased activity associated with a vigilance decrement 
might counteract the performance decrement and the increase 
in subjective fatigue.
Currently, only few studies have investigated the effect of tDCS 
on MS-related fatigue (41–43). While some of these studies point 
to a beneficial effect of stimulation over motor or somatosensory 
brain regions on subjective fatigue (41, 43), other studies, stimu-
lating the prefrontal cortex, did not find significant effects of 
tDCS (42). However, these studies investigated the effect of tDCS 
only on subjective fatigue or fatigue complaints, not on objective 
fatigue measures, such as the vigilance decrement.
The main objective of this study was to investigate whether 
anodal tDCS over the right frontal or the right parietal cortex 
might be able to counteract vigilance decrement in cognitively 
fatigued MS patients. Several studies point to an association 
between MS-related fatigue and structural as well as functional 
changes within right frontal and parietal brain areas that con-
stitute the vigilance network (27–37). Therefore, we assume 
that anodal, excitability-enhancing tDCS over these brain areas 
should be able to counteract fatigue-related vigilance decrement 
in MS patients. We first performed a randomized double-blind 
placebo-controlled study investigating healthy individuals to 
check whether right frontal or right parietal stimulation provides 
the best outcome with respect to vigilance performance (study 
I). The anodal stimulation with the best outcome was then tested 
in study II, in which the effect of stimulation on both objective 
and subjective fatigue was analyzed in cognitively fatigued MS 
patients.
sTUDY i
Methods
Study Population
Fifty-two healthy individuals aged between 19 and 44 years par-
ticipated in this study. Most were students from the Department 
of Psychology of the University of Bremen. Participants were 
recruited via an internal mail delivery system and postings.
Individuals that were pregnant or had metallic head implants, 
a history of epilepsy, or any other neurological disease were 
excluded. The study was approved by the ethical board of the 
Medical Chamber in Bremen, and written informed consent was 
obtained from participants.
Study Design
To compare the efficacy of anodal tDCS over the right frontal 
vs. right parietal cortex, we designed a randomized double-
blind placebo-controlled study (Table  1). Participants were 
randomized to receive sham tDCS (n = 17), active anodal tDCS 
over the right parietal cortex (n =  18), or active anodal tDCS 
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over the right frontal cortex (n = 17). Participants were allotted 
to a condition using the order of entrance in the study and a 
previously generated randomization list. Neither the participants 
nor the director of the study were aware of the stimulation 
condition. All participants performed a 40-min vigilance 
task. During the first 20 min of the task, participants received 
either active anodal tDCS or placebo tDCS. After 20 min, the 
intervention stopped automatically, and the vigilance task was 
continued without stimulation. As primary outcome measure, 
we focused on the progress of RTs and errors in the vigilance 
task (omissions +  commissions) because these measures were 
frequently found to increase with time-on-task (2, 8, 9). Based on 
a power calculation for the MS patients, we compared vigilance 
performance during the first 5 min with that of the last 5 min 
(2). Information about general fatigue, depression, daytime 
sleepiness, and sleep quality was assessed to investigate possible 
associations with performance level.
Visual Vigilance Task
The computer-based visual vigilance task of the test battery for 
attentional performance [TAP 1.7; (44)] was used. Participants 
were sitting alone in a darkened room observing a bar on a screen 
that moved upwards and downwards with changing amplitudes 
in height. They were instructed to detect obviously larger upward 
amplitudes by pressing a key as quickly as possible. The frequency 
of critical stimuli was tuned very low to provide highly monoto-
nous task conditions. The interval between critical stimuli varied 
randomly between 15,000 and 90,000 ms, with ~6 critical stimuli 
occurring during each 5 min period of testing. Participants were 
monitored via Skype to ensure that they continuously conducted 
the task.
Participants first performed a practice trial (with a slightly 
higher frequency of critical stimuli) for ~1 min to adapt to the 
task. Time-on-task effects were determined by comparing median 
RTs and the number of errors in the first (BEGIN) and last (END) 
5 min of the vigilance task.
Psychological Assessment
Participants rated their current feelings of general fatigue before 
(VAS1) and after (VAS2) the vigilance task using a 100-mm 
visual analog scale [(VAS); 0 = no fatigue at all, 100 = maximal 
imaginable fatigue].
Fatigue was also assessed using self-reported questionnaires, 
namely the Fatigue Severity Scale [FSS; (45)] and the Fatigue 
Scale for Motor and Cognitive Functions [FSMC; (46)]. The FSS 
consists of nine items assessing severity and frequency of fatigue, 
with higher scores representing stronger fatigue. The FSMC is 
composed of 20 items and evaluates two main components of 
fatigue, namely motor and cognitive fatigue. The cutoff score 
between normal and mild pathological fatigue is 43 for the total 
scale and 22 for the cognitive and motor scale.
Information about daytime sleepiness, sleep quality, and 
depression was assessed via specific questionnaires. The Epworth 
Sleepiness Scale [ESS; (47)] was used to assess daytime sleepiness. 
Sleep quality was determined using the Pittsburgh Sleep Quality 
Index [PSQI; (48)]. Depressive mood was investigated using the 
Beck Depression Inventory Scale [BDI; (49)].
Stimulation
Anodal tDCS with an intensity of 1.5 mA and with a duration of 
20 min was applied using a battery-driven constant current stimu-
lator (DC-Stimulator Plus, NeuroConn, Ilmenau, Germany). The 
current was ramped up for 30 s until reaching 1.5 mA intensity 
and ramped down for 30 s at the end of the stimulation. For the 
placebo stimulation, the current was ramped up for 8 s followed 
by 30 s of stimulation and a ramping down period of 5 s. During 
the rest of the placebo intervention period, every 550 ms, a cur-
rent of 110 μA was released to provide effective blinding. The 
stimulation electrodes were coated in sponges that were soaked 
in isotonic saline solution. The anode (5 cm × 7 cm) was either 
placed over the right parietal cortex (P4 in 10–20 EEG system) or 
the right frontal cortex (F4 in 10–20 EEG system). The cathode 
(5 cm × 7 cm) was always placed on the contralateral forehead 
(current density in the active tDCS conditions = 0.04 mA/cm2). 
In the placebo group, the anode was either located over the right 
parietal cortex (P4) or over the right frontal cortex (F4). The 
cathode was invariably placed over the left forehead (Figure 1).
Statistical Analysis
Repeated measures analyses of variance (ANOVA) were used 
to check for group differences in vigilance performance (RT 
and errors) and subjective fatigue (VAS) using SPSS21 software. 
The treatment condition (VERUM F4/VERUM P4/PLACEBO) 
was defined as between-subject factor GROUP. With respect to 
vigilance performance, we defined TIME (BEGIN/END) as the 
within-group factor. Concerning subjective fatigue, respective 
fatigue level before and after the vigilance test were defined as 
within-group factors TIME (BEFORE/AFTER). Significant main 
or interaction effects were further tested using post hoc tests.
results
Demographic and Psychological Data
Three participants were excluded from the analyses because 
investigations were interrupted during the vigilance task. Another 
participant was excluded because of falling asleep during the 
vigilance task (Figure 2).
Individuals (n = 48) in the three groups did not differ in terms 
of age, gender, fatigue scores, depression score, or daytime sleepi-
ness. All groups displayed mean FSMC scores suggesting mild 
pathological fatigue. The placebo group scored significantly lower 
on the PSQI than the frontal stimulation group (Table 2).
Performance on the Vigilance Task
The ANOVA on RTs revealed no main effects, but a significant 
interaction between GROUP and TIME (p = 0.032; F = 3.73). 
The parietal stimulation group showed a decrease in RT with 
time-on-task, whereas the other two groups presented an 
increase in RT (Figure 3). Post hoc independent t-tests revealed 
no significant group differences in RT during the first 5 min of 
the vigilance task. In the last 5 min of the vigilance task, a signifi-
cant difference between the frontal and the parietal stimulation 
group was observed (p =  0.026), with the frontal stimulation 
group presenting significantly longer RTs. Post hoc dependent 
t-tests revealed a significant increase in RT with time-on-task for 
the frontal stimulation group (p = 0.020), whereas the parietal 
FigUre 1 | Position of electrodes in the 10–20 eeg system. Left: parietal stimulation group with anode (red) located over P4 and the cathode (blue) placed 
over the contralateral forehead. Right: frontal stimulation group with the anode (red) located over F4 and the cathode (blue) placed over the contralateral forehead.
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stimulation group showed a moderate decrease in RT (p = 0.074; 
Table 2).
The ANOVA on errors showed no significant effect of GROUP 
or an interaction with GROUP. However, there was a significant 
main effect of TIME (p =  0.003; F =  10.08), with all groups 
making more errors in the first 5 min than in the last 5 min of 
the vigilance task. Post hoc Wilcoxon tests revealed a significant 
decrease for the placebo (p = 0.019) and the parietal stimulation 
group (p = 0.004).
Subjective Fatigue
The analysis of the VAS data before and after the vigilance task 
revealed a significant main effect of TIME (p < 0.001; F = 24.8), 
with all groups showing an increase in the VAS score. Post hoc 
dependent t-tests demonstrated that the increase on the VAS was 
significant for the placebo (p = 0.002) and the frontal stimulation 
group (p =  0.005), but not for the parietal stimulation group 
(p = 0.063).
Discussion
Our results suggest that anodal stimulation of the right parietal 
cortex exerts a positive effect on the decrement of RT, unlike 
stimulation over the right frontal cortex that even seems to exert a 
negative effect on vigilance performance. Subjective fatigue level 
before and after the vigilance task revealed a significant increase 
for the placebo and the frontal stimulation group, but not for the 
parietal group. On the basis of these results, we decided to use 
only anodal stimulation of the right parietal cortex in study II.
sTUDY ii
Methods
Study Population
Forty-six MS patients with a relapsing–remitting (n = 18) or a 
secondary progressive (n = 28) disease course according to the 
McDonald criteria (50) participated in this study. A required 
sample size of at least 40 MS patients was determined on the basis 
of the data of a former study, in which we investigated the effect 
of a cooling vest on vigilance performance (2). We identified a 
significance level α of 0.05 and a power of 0.80. The relevant dif-
ference was determined as the standardized mean difference of 
the vigilance performance data.
Patients were recruited from MS support groups or have 
been patients of the Klinikum Bremen-Ost, Germany. Patients 
received either disease-modifying drugs (67%) or no therapy 
(33%). Individuals with a MS relapse or using corticosteroids 
during the last four weeks, under legal care and/or with a diag-
nosis of any other neurodegenerative disease were excluded from 
the study. Further exclusion criteria were the presence of metallic 
head implants, a history of epilepsy, and pregnancy. The study was 
approved by the ethical board of the Medical Chamber in Bremen, 
and written informed consent was obtained from participants.
FigUre 2 | Flowchart of study i.
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Study Design
We designed a randomized double-blind placebo-controlled 
study (Table 3). Patients were randomized to receive sham tDCS 
(n =  23) or active anodal tDCS over the right parietal cortex 
(n  =  23). Randomization was performed using the order of 
entrance in the study and a previously generated randomization 
list. tDCS was applied for 20 min before performing a 20-min 
visual vigilance task, unlike in study I.
Visual Vigilance Task
The visual vigilance task was identical to that in study I, but lasted 
20 min, and was performed directly after a 20-min stimulation 
period.
Psychological and Clinical Assessment
Psychological assessment was identical to that of study I, but a 
neurological disability assessment was added, using a question-
naire that addresses the different aspects considered in the 
Expanded Disability Status Scale (51).
The VAS was assessed directly before (VAS1) and after (VAS2) 
stimulation and after the vigilance task (VAS3).
Stimulation
Stimulation was applied in the same way as in study I. In the 
verum, and in the placebo group, the anode (5  cm  ×  7  cm) 
was placed over the right parietal cortex (P4), and the cathode 
(5 cm × 7 cm) was placed over the contralateral forehead.
Statistical Analysis
Analyses of variances were used to check for group differences 
in performance on the vigilance task (median RT, errors) and in 
subjective fatigue (VAS). The treatment condition (VERUM vs. 
PLACEBO) was defined as between-subject factor TREATMENT. 
To control for a possible effect of the level of cognitive fatigue 
on the efficacy of stimulation, we divided patients into those 
suffering from severe cognitive fatigue and those suffering 
from mild to moderate cognitive fatigue, based on the median 
cognitive fatigue score of the FSMC. Accordingly, we included 
the cognitive fatigue level (MILD/MODERATE vs. SEVERE) as 
a second between-subject factor FATIGUE. We compared RTs 
and number of errors from the first (BEGIN) and last (END) 
5 min of the vigilance task and defined TIME (BEGIN vs. END) 
as within-group factor. Changes in subjective fatigue level were 
TaBle 2 | Demographic, psychological, and reaction time data of study 
participants (study i).
study i
right frontal 
tDcs
right parietal 
tDcs
Placebo 
tDcs
Number (n) 16 16 16
Age (SD) 27.13 (7.71) 26.19 (6.42) 23.75 (2.70)
Gender (male:female) 4:12 4:12 3:13
FSS (SD) 2.98 (0.66) 2.9 (0.94) 3.09 (1.08)
FSMC total score (SD) 47.69 (7.96) 45.81 (8.60) 44.50 (10.56)
FSMC cognitive score (SD) 24.13 (5.62) 22.69 (4.84) 21.75 (5.98)
FSMC motor score (SD) 23.69 (3.42) 23.13 (5.15) 22.75 (5.13)
ESS (SD) 7.75 (2.72) 8.63 (3.90) 8.94 (2.79)
PSQI (SD)* 6.97 (3.26) 5.50 (2.92) 4.59 (2.08)
BDI (SD) 7.75 (4.60) 6.19 (4.63) 6.38 (4.10)
VAS1 (before vigilance task) 
(SD)
43.73 (24.86) 39.63 (21.25) 40.19 (24.58)
VAS2 (after vigilance task) 
(SD)
60.44 (28.86) 53.00 (26.21) 57.38 (18.16)
RT (SD) vigilance task first 
5 min
438.6 (±115.8) 443.1 (±68.5) 409.8 (±85.5)
RT (SD) vigilance task last 
5 min**
489.8 (±116.5) 411.2 (±62.8) 426.4 (±113.5)
*p < 0.05 (significant difference between placebo stimulation and right frontal 
stimulation group).
**p < 0.05 (significant difference between right frontal and right parietal stimulation 
group).
BDI, Beck’s Depression Inventory; FSMC, Fatigue Scale for Motor and Cognition; FSS, 
Fatigue Severity Scale; ESS, Epworth Sleepiness Scale; PSQI, Pittsburgh Sleep Quality 
Index; RT, reaction time; VAS Visual Analog Scale.
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analyzed using the VAS1, VAS2, and VAS3 as within-group 
factor TIME. Significant main or interaction effects were tested 
further using post hoc tests.
results
Demographic and Psychological Data
All patients had at least a cognitive fatigue scale value of 22 
on the FSMC. Five patients were excluded from the analysis 
because they fell asleep during the vigilance test. Three of them 
belonged to the placebo group, two to the verum group. Another 
patient was excluded from the analysis because of missing and/
or insufficient RT data for most 5-min intervals of the vigilance 
task (Figure 4). Mildly to moderately cognitively fatigued and 
severely cognitively fatigued patients of the placebo and the 
stimulation group did only differ in fatigue assessments, with 
mildly to moderately fatigued patients scoring significantly 
lower on these assessments than severely cognitively fatigued 
patients (Table 4).
Performance on the Vigilance Task
The ANOVA on RTs revealed a significant interaction effect 
for TREATMENT ×  TIME (p =  0.043; F =  4.381) as well as 
for TREATMENT × FATIGUE × TIME (p = 0.013; F = 6.826). 
While the verum group showed a decrease in RT with time-
on-task [begin: 570.3 ms (±110.7); end: 549.7 ms (±90.3)], the 
placebo group presented an increase [begin: 496.4 ms (±124.0); 
end: 530.4 ms (±98.5)]. When considering the different fatigue 
groups, the positive effect of stimulation on RTs was more 
pronounced in MS patients suffering from mild to moderate 
fatigue than in severely cognitively fatigued patients (Figure 5). 
While mildly to moderately cognitively fatigued MS patients of 
the stimulation group presented a moderate decrease in RTs with 
time-on-task [begin: 591.5 ms (±105.5); end: 548.6 ms (±92.5); 
p = 0.097], severely cognitively fatigued patients of the stimula-
tion group showed hardly any change in RTs [begin: 549.2 ms 
(±117.3); end: 550.9 ms (±92.9); p = 0.957]. The change in RT 
differed significantly between mildly to moderately cognitively 
fatigued MS patients of the placebo and the stimulation group 
(p = 0.012). While those patients belonging to the stimulation 
group showed a moderate decrease in RTs with time-on-task 
(p =  0.097), those belonging to the placebo group showed a 
significant increase in RTs (p = 0.030). There was no correlation 
between the level of depression and the performance on the 
vigilance task.
The ANOVA on the number of errors did not reveal any 
significant main or interaction effects.
Subjective Fatigue
The ANOVA on the VAS data revealed significant differences 
between fatigue groups (p =  0.017; F =  6.236). Post hoc tests 
showed that patients suffering from severe cognitive fatigue 
scored significantly higher on the VAS data assessed before 
(p = 0.044) and after the vigilance task (p = 0.009) than patients 
with mild to moderate cognitive fatigue. Moreover, the ANOVA 
revealed a significant effect of TIME (p < 0.001; F = 9.006). All 
groups presented a decrease in their subjective fatigue level when 
comparing VAS data assessed before (VAS1) and after (VAS2) 
stimulation. The comparison between the VAS data assessed 
before (VAS2) and after (VAS3) vigilance performance demon-
strated an increase in subjective fatigue level for all groups. There 
were no significant interaction effects between different groups 
(TREATMENT; FATIGUE) and the factor TIME.
Discussion
Our results suggest that anodal stimulation over the right parietal 
cortex exerts a positive effect on the decrement of RT during a 
vigilance task. Patients who received anodal stimulation over 
the right parietal cortex showed a decrease in their RT with 
time-on-task, whereas patients of the placebo group presented 
an increase in their RT with ongoing time. The positive effect of 
stimulation was only observed in patients suffering from mild to 
moderate cognitive fatigue, not in severely cognitively fatigued 
patients. All groups presented an increase in subjective fatigue 
after the vigilance task. This increase was independent of stimula-
tion, suggesting a dissociation between behavioral and subjective 
measures of fatigue. This assumption is compatible with our 
model for MS-related fatigue (52).
general Discussion
The results of study I and study II indicate that anodal stimula-
tion over the right parietal cortex counteracts the performance 
decrement during a vigilance task, which is primarily reflected 
in the RT data. In both studies, individuals receiving anodal 
stimulation over the right parietal cortex showed a decrease in 
RT with time-on-task, in comparison to individuals receiving 
TaBle 3 | study design of study ii.
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FigUre 3 | Median reaction times of the stimulation groups for the first and last 5 min of the vigilance test. Error bars reflect SDs.
7
Hanken et al. tDCS in Fatigued MS Patients
Frontiers in Neurology | www.frontiersin.org September 2016 | Volume 7 | Article 154
frontal or placebo stimulation. In MS patients, the positive effect 
of parietal stimulation was restricted to patients suffering from 
mild to moderate cognitive fatigue.
The positive effect of right parietal stimulation is likely to be 
ascribed to enhanced excitability in the parietal cortex resulting 
from anodal tDCS. Neuroimaging studies demonstrated that 
vigilance relies on a right-hemispheric frontal, parietal, thalamic, 
and brainstem network (18–20), and previous studies frequently 
reported an association between vigilance decrement and a 
decrease of neural activity in the thalamus, the right-hemispheric 
ventro–dorsolateral frontal, parietal, and temporal cortex (11, 
22–24). Moreover, several studies on structural correlates of 
MS-related fatigue demonstrated an association between fatigue 
and atrophy within the parietal lobe (27, 28, 31, 32, 34). Therefore, 
anodal excitability-enhancing tDCS over the right parietal cortex 
may counteract vigilance decrement by enhancing processing in 
the parietal cortex.
The observed decline in RT appeared at the end of the 
vigilance test, after stimulation was stopped. Previous studies 
demonstrated that the effect of tDCS persists minutes to hours 
after stimulation ended, depending on stimulation parameters 
and cortical areas that have been stimulated (53). Therefore, it 
seems that the decline in RT may be ascribed to after-effects of 
parietal stimulation.
Our results indicate that stimulation is more effective in MS 
patients suffering from mild to moderate cognitive fatigue than in 
those suffering from severe cognitive fatigue. The four composed 
groups of MS patients did not differ in the severity of depres-
sion. Hence, we assume that the obtained results are not due to 
differences in the level of depression. Severely fatigued patients 
might suffer from increased atrophy or a larger neurotransmitter 
imbalance in stimulated brain areas, which might explain the 
reduced effect of stimulation in this group. Several MRI studies 
on structural correlates of MS-related fatigue point to a positive 
correlation between fatigue level and atrophy within parietal 
brain regions (28, 32, 34). Probably, duration and intensity of 
stimulation were not sufficient to exert a positive effect in severely 
cognitively fatigued patients. However, these considerations need 
to be investigated further.
In contrast to our hypothesis, stimulation of the right frontal 
cortex did not reveal positive effects on vigilance performance. 
Healthy individuals receiving frontal stimulation performed 
even worse with respect to RT than the placebo group. This 
finding is in line with results obtained by Nelson and colleagues 
(54). These authors compared the effect of anodal stimulation 
FigUre 4 | Flowchart of study ii.
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over the left frontal cortex (anode F3; cathode F4) with that 
of anodal stimulation over the right frontal cortex (anode F4; 
cathode F3) on vigilance performance and found no effect on 
RT. Both groups presented an increase in RT with time-on-task. 
The negative effect of right frontal stimulation that we observed 
might point to a possible effect of stimulation on task-irrelevant 
information processing. Frontal stimulation might induce 
changes in neural excitability resulting in increased neural pro-
cessing within brain areas that process interoceptive information. 
Consequently, frontal stimulation might cause interoceptive 
interference distracting cognitive processes causing an increase 
in RT. Moreover, stimulation of the frontal cortex might increase 
mind wandering. This assumption is supported by Axelrod and 
colleagues (55) who demonstrated that stimulation of the frontal 
cortex has the potential to increase the propensity to mind wan-
der. Anodal excitability-enhancing stimulation over the right 
frontal cortex might also increase inter-hemispheric inhibition 
of the left frontal cortex resulting in slower motor responses and 
performance decline. However, these interpretations are rather 
speculative, and we cannot say which mechanisms cause the 
vigilance decrement in the frontal stimulation group, but right 
frontal anodal tDCS appears to exert negative effects on RTs 
during a vigilance task.
Healthy controls scored in the range of mild pathological 
fatigue concerning the FSMC. However, according to the results 
on the FSS, healthy controls did not display a pathological fatigue 
level. This apparent discrepancy between the two questionnaires 
might well be due to different definitions of the cutoff value for 
pathological fatigue. Presumably, for the FSMC, the cutoff value 
for fatigue is set quite low to get a highly sensitive measure for 
fatigue. However, at the same time, the specificity of the ques-
tionnaire decreases. Such a difference between questionnaires 
may also explain why several healthy individuals displayed a 
pathological fatigue level on the FSMC.
Concerning vigilance performance, healthy controls made 
more errors at the beginning than at the end of the vigilance 
task. This finding is mainly due to the amount of commissions 
and might result from an uncertainty about the occurrence 
of target stimuli at the beginning of the task. With ongoing 
time, individuals perhaps become more familiar with the task 
TaBle 4 | Demographic, psychological, and reaction time data of multiple sclerosis patients (study ii).
study ii
Verum Placebo
Mild/moderate cF severe cF Mild/moderate cF severe cF
Number of individuals 10 10 10 10
Age (SD) 51.8 (9.9) 50.9 (8.8) 47.1 (10.3) 46.5 (9.1)
Gender (male:female) 4:6 3:7 4:6 4:6
Disease duration in month (SD) 142.8 (75.2) 135.2 (86.3) 180.1 (136.5) 126.8 (101.8)
Symptom duration in month (SD) 228.0 (135.7) 276.7 (111.3) 223.9 (130.2) 186.9 (109.1)
Disease type (RRMS:CPMS) 5:5 3:7 4:6 3:7
Disease-modifying therapy (no:yes) 3:7 2:8 4:6 4:6
EDSS (SD) 4.0 (1.5) 4.8 (1.2) 3.4 (2.1) 4.5 (1.0)
FSS (SD)*,a 3.92 (1.16) 5.61 (0.93) 4.06 (1.60) 5.27 (1.33)
FSMC total score (SD)*,a,b,c,d 65.1 (7.1) 84.6 (8.6) 56.3 (8.0) 79.3 (11.6)
FSMC cognitive score (SD)*,a,b,c,d 31.6 (3.5) 42.3 (5.1) 27.2 (3.8) 40.8 (5.0)
FSMC motor score (SD)*,a,b,c 33.5 (4.7) 42.3 (4.4) 29.1 (4.5) 38.5 (6.9)
ESS (SD) 7.8 (4.5) 11.2 (4.2) 9.8 (3.8) 9.0 (3.4)
PSQI (SD) 7.2 (4.2) 10.4 (4.5) 6.8 (3.3) 8.2 (3.3)
BDI (SD) 11.9 (9.8) 14.8 (8.4) 10.3 (7.2) 11.4 (6.6)
VAS1 (before tDCS) (SD) 43.8 (24.9) 52.8 (26.5) 30.8 (19.1) 39.5 (24.9)
VAS2 (after tDCS) (SD) 32.3 (20.6) 44.0 (27.1) 20.0 (12.3) 38.0 (26.7)
VAS2 (before vigilance task) (SD) 32.3 (20.6) 44.0 (27.1) 20.0 (12.3) 38.0 (26.7)
VAS3 (after vigilance task) (SD)*,c 43.9 (28.1) 63.2 (24.9) 28.7 (22.8) 53.9 (25.1)
RT (SD) vigilance task (first 5 min) 591.5 (±105.5) 549.2 (±117.3) 473.4 (±120.1) 519.5 (±129.8)
RT (SD) vigilance task (last 5 min) 548.6 (±92.5) 550.9 (±92.9) 553.2 (±106.8) 507.6 (±89.1)
*p < 0.05.
aMildly/moderately cognitively fatigued verum vs. severely cognitively fatigued verum.
bMildly/moderately cognitively fatigued placebo vs. severely cognitively fatigued placebo.
cMildly/moderately cognitively fatigued placebo vs. severely cognitively fatigued verum.
dMildly/moderately cognitively fatigued verum vs. severely cognitively fatigued placebo.
BDI, Beck Depression Inventory; CF, cognitive fatigue; CPMS, chronic progressive multiple sclerosis; EDSS, Expanded Disability Status Scale; ESS, Epworth Sleepiness Scale; 
FSMC, Fatigue Scale for Motor and Cognition; FSS, Fatigue Severity Scale; PSQI, Pittsburgh Sleep Quality Index; RRMS, relapsing–remitting multiple sclerosis; RT, reaction time; 
VAS, Visual Analog Scale.
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characteristics, and consequently the number of commissions 
may decrease. Overall, the decrease in the number of errors 
with time-on-task indicates that the positive effect of parietal 
stimulation on RTs cannot be interpreted as a speed–accuracy 
tradeoff phenomenon.
A large increase in subjective fatigue was observed in all groups 
after the vigilance task, with severely cognitively fatigued patients 
presenting generally higher scores than mildly to moderately cog-
nitively fatigued patients. Moreover, we excluded 5 out of 46 MS 
patients and 1 out of 52 healthy controls from the analysis because 
they fell asleep several times during the vigilance task. This dem-
onstrates that the vigilance task is highly sensitive to fatigue in MS 
patients and has a great potential to induce increased subjective 
fatigue. Hence, a 20-min lasting vigilance task might present a 
valid diagnostic tool for objectively measuring cognitive fatigue 
in MS patients.
Stimulation had no effect on subjective fatigue. At first sight, 
this finding seems to contradict the behavioral data revealing a 
positive effect of parietal stimulation on the decrement of RTs. 
However, this finding is compatible with our model for fatigue in 
MS, which predicts exactly such a dissociation between the feel-
ing and the behavioral characteristics of fatigue (52). According 
to this model, subjective fatigue in MS depends on peripheral 
inflammation and inflammation-induced activity changes 
within homeostatic brain regions like the hypothalamus, the 
anterior cingulated, or the insular cortex. Right parietal stimula-
tion does not influence peripheral inflammation and resulting 
inflammation-induced activity changes within homeostatic brain 
regions. The behavioral aspects of fatigue seem to depend on focal 
brain atrophy and/or neurotransmitter imbalance affecting the 
alerting/vigilance network, including areas in the parietal lobe. 
Recently, we published a study on cortical underpinnings for 
fatigue in MS and demonstrated that fatigued patients present 
reduced cortical thickness within the right inferior parietal lobe 
(31). Consequently, excitability-enhancing anodal stimulation 
over the right parietal cortex should be able to increase excitabil-
ity within the vigilance network and reduce vigilance decrement 
in fatigued MS patients, but it should not have any effects on the 
feeling of fatigue.
One limitation of our study is that the stimulation condi-
tions in study I and study II slightly differed. While in study I, 
stimulation occurred during the first half of the 40-min lasting 
vigilance task, in study II, stimulation was applied before the 
20-min lasting vigilance performance. Due to safety issues, 
we did not exceed a stimulation period of 20 min. We decided 
to apply tDCS in study II before the vigilance task, because 
in study  I, differences between groups mainly arose after 
stimulation stopped. Moreover, we shortened the duration of 
the vigilance task in study II to minimize stress for fatigued MS 
patients. Nevertheless, we did find a positive effect of stimula-
tion on vigilance decrement in study II. Furthermore, we did 
not assess vigilance performance before the stimulation. It would 
have been interesting to compare the assessed RTs with those 
measured before any intervention occurred. Moreover, evidence 
suggests that bilateral anodal stimulation might be even more 
effective than unilateral stimulation in enhancing cognitive 
functions, such as vigor activity (56). Two recent studies used 
bilateral anodal stimulation and found a positive effect of tDCS 
on subjective fatigue in MS (41, 43), suggesting that bilateral 
stimulation might produce even better effects on objective and 
subjective fatigue than unilateral stimulation.
In conclusion, our results indicate that anodal tDCS over the 
right parietal, but not over the right frontal cortex, can coun-
teract the increase in RT that is frequently observed during a 
vigilance task. The positive effect of stimulation on the decrease 
in RTs was only observed in MS patients suffering from mild to 
moderate cognitive fatigue, suggesting that anodal tDCS might 
be a useful method to counteract fatigue-associated perfor-
mance decline in MS patients that suffer from mild to moderate 
cognitive fatigue.
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